drugset / Trial / NCT00154011
Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.
RandomizedParallel-groupDouble-blindTreatment
Summary
The study is designed to test the hypothesis in healthy subjects that the oral antidiabetic drug rosiglitazone provides additional vascular relaxing or modulating effects in addition to its blood glucose level reducing ability.
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosiglitazone | Small molecule | 8 mg | Oral |
Indications
No indication recorded.